BCL2 and neoplasm: BCL2, a class of anti-apoptotic proteins, modulates apoptosis and promotes survival in tumor cells (Carrington et al., 2017); While, the pro-apoptotic proteins BAX, and BAD, residing on the mitochondrial membrane is usually downregulated in tumor cells (Garrido et al., 2006).